Cover Image
Market Research Report
Product code 
1035641

Bioanalytical Testing Services Market Research Report by Type, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 188 Pages | Delivery time: 1-2 business days

Price

Back to Top
Bioanalytical Testing Services Market Research Report by Type, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: November 4, 2021
360iResearch LLP
Content info: 188 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Bioanalytical Testing Services Market size was estimated at USD 3,317.14 million in 2020 and expected to reach USD 3,619.00 million in 2021, at a CAGR 9.43% to reach USD 5,698.79 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Bioanalytical Testing Services to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation, Pharmacokinetic Testing, Serology, Immunogenicity, & Neutralizing Antibodies, and Virology Testing. The Cell-Based Assays is further studied across Bacterial Cell-Based Assays and Viral Cell-Based Assays. The Virology Testing is further studied across In Vitro Virology Testing, In Vivo Virology Testing, and Species-Specific Viral PCR Assays.
  • Based on Application, the market was studied across Cardiology, Gastroenterology, Infectious Diseases, Neurology, and Oncology.
  • Based on End User, the market was studied across Contract Development & Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioanalytical Testing Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bioanalytical Testing Services Market, including Almac Group, Altasciences Company, Inc., BioAgilytix Labs, LLC, Celerion, Charles River Laboratories International, Inc., Eurofins Scientific, Frontage Laboratories, Inc., Icon PLC, Intertek Group plc, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, LGC Group, Lotus Labs Pvt. Ltd., Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Research Associates Inc., PPD Inc., SGS SA, Syneos Health, LLC, and WuXi AppTec Co., Ltd.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Bioanalytical Testing Services Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioanalytical Testing Services Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioanalytical Testing Services Market?
  • 4. What is the competitive strategic window for opportunities in the Global Bioanalytical Testing Services Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Bioanalytical Testing Services Market?
  • 6. What is the market share of the leading vendors in the Global Bioanalytical Testing Services Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Bioanalytical Testing Services Market?
Product Code: MRR-F949FCDE09C4

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus on the analytical testing of biologics and biosimilars
      • 5.1.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
      • 5.1.1.3. Rising adoption of the quality by design approach
    • 5.1.2. Restraints
      • 5.1.2.1. Pricing pressure and dearth of skilled professionals faced by major players
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for specialized bioanalytical testing services in developing economies
      • 5.1.3.2. Increasing economic efficiency offered for outsourcing rather than conducting an in-house study
      • 5.1.3.3. Emergence of technological advancements and approvals of clinical trials in the bioanalytical testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding innovative formulations demanding a unique bioanalytical testing approach
  • 5.2. Cumulative Impact of COVID-19

6. Bioanalytical Testing Services Market, by Type

  • 6.1. Introduction
  • 6.2. Biomarker Testing
  • 6.3. Cell-Based Assays
    • 6.3.1. Bacterial Cell-Based Assays
    • 6.3.2. Viral Cell-Based Assays
  • 6.4. Method Development Optimization & Validation
  • 6.5. Pharmacokinetic Testing
  • 6.6. Serology, Immunogenicity, & Neutralizing Antibodies
  • 6.7. Virology Testing
    • 6.7.1. In Vitro Virology Testing
    • 6.7.2. In Vivo Virology Testing
    • 6.7.3. Species-Specific Viral PCR Assays

7. Bioanalytical Testing Services Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Gastroenterology
  • 7.4. Infectious Diseases
  • 7.5. Neurology
  • 7.6. Oncology

8. Bioanalytical Testing Services Market, by End User

  • 8.1. Introduction
  • 8.2. Contract Development & Manufacturing Organizations
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Bioanalytical Testing Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioanalytical Testing Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Bioanalytical Testing Services Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Almac Group
  • 13.2. Altasciences Company, Inc.
  • 13.3. BioAgilytix Labs, LLC
  • 13.4. Celerion
  • 13.5. Charles River Laboratories International, Inc.
  • 13.6. Eurofins Scientific
  • 13.7. Frontage Laboratories, Inc.
  • 13.8. Icon PLC
  • 13.9. Intertek Group plc
  • 13.10. IQVIA Holdings, Inc.
  • 13.11. Laboratory Corporation of America Holdings
  • 13.12. LGC Group
  • 13.13. Lotus Labs Pvt. Ltd.
  • 13.14. Medpace Holdings, Inc.
  • 13.15. Parexel International Corporation
  • 13.16. Pharmaceutical Research Associates Inc.
  • 13.17. PPD Inc.
  • 13.18. SGS SA
  • 13.19. Syneos Health, LLC
  • 13.20. WuXi AppTec Co., Ltd

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2026
  • FIGURE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER TESTING, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BACTERIAL CELL-BASED ASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BACTERIAL CELL-BASED ASSAYS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIRAL CELL-BASED ASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIRAL CELL-BASED ASSAYS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METHOD DEVELOPMENT OPTIMIZATION & VALIDATION, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METHOD DEVELOPMENT OPTIMIZATION & VALIDATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC TESTING, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SEROLOGY, IMMUNOGENICITY, & NEUTRALIZING ANTIBODIES, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SEROLOGY, IMMUNOGENICITY, & NEUTRALIZING ANTIBODIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO VIROLOGY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO VIROLOGY TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO VIROLOGY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO VIROLOGY TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECIES-SPECIFIC VIRAL PCR ASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 31. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GASTROENTEROLOGY, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 42. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2026
  • FIGURE 44. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 62. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 63. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 64. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 66. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 67. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 68. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 69. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 70. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 71. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 72. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 73. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 74. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 75. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 76. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 77. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 78. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 79. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 80. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 81. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BACTERIAL CELL-BASED ASSAYS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIRAL CELL-BASED ASSAYS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METHOD DEVELOPMENT OPTIMIZATION & VALIDATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC TESTING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SEROLOGY, IMMUNOGENICITY, & NEUTRALIZING ANTIBODIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO VIROLOGY TESTING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO VIROLOGY TESTING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 21. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
  • TABLE 22. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 23. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 24. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 25. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 51. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 52. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 53. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 54. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 55. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: SCORES
  • TABLE 56. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BUSINESS STRATEGY
  • TABLE 57. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: PRODUCT SATISFACTION
  • TABLE 58. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: RANKING
  • TABLE 59. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 60. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: MERGER & ACQUISITION
  • TABLE 61. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 62. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 63. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: INVESTMENT & FUNDING
  • TABLE 64. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 65. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: LICENSE & PRICING